GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnax Lab Ltd (BOM:506128) » Definitions » E10

Parnax Lab (BOM:506128) E10 : ₹5.26 (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Parnax Lab E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Parnax Lab's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹1.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹5.26 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Parnax Lab's average E10 Growth Rate was 10.30% per year. During the past 3 years, the average E10 Growth Rate was 36.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Parnax Lab was 36.00% per year. The lowest was 36.00% per year. And the median was 36.00% per year.

As of today (2025-04-05), Parnax Lab's current stock price is ₹108.15. Parnax Lab's E10 for the quarter that ended in Dec. 2024 was ₹5.26. Parnax Lab's Shiller PE Ratio of today is 20.56.

During the past 13 years, the highest Shiller PE Ratio of Parnax Lab was 39.74. The lowest was 8.57. And the median was 18.23.


Parnax Lab E10 Historical Data

The historical data trend for Parnax Lab's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnax Lab E10 Chart

Parnax Lab Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.05 3.97 4.63 5.16

Parnax Lab Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.77 5.16 5.43 5.46 5.26

Competitive Comparison of Parnax Lab's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Parnax Lab's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parnax Lab's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnax Lab's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Parnax Lab's Shiller PE Ratio falls into.


;
;

Parnax Lab E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Parnax Lab's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.06/158.3229*158.3229
=1.060

Current CPI (Dec. 2024) = 158.3229.

Parnax Lab Quarterly Data

per share eps CPI Adj_EPS
201503 -0.080 97.163 -0.130
201506 1.000 99.841 1.586
201509 1.650 101.753 2.567
201512 0.990 102.901 1.523
201603 0.310 102.518 0.479
201606 1.880 105.961 2.809
201609 1.270 105.961 1.898
201612 1.910 105.196 2.875
201703 0.350 105.196 0.527
201706 0.180 107.109 0.266
201709 3.419 109.021 4.965
201712 0.750 109.404 1.085
201803 -3.120 109.786 -4.499
201806 0.850 111.317 1.209
201809 4.890 115.142 6.724
201812 0.460 115.142 0.633
201903 -2.321 118.202 -3.109
201906 0.090 120.880 0.118
201909 0.419 123.175 0.539
201912 -0.970 126.235 -1.217
202003 -3.017 124.705 -3.830
202006 0.270 127.000 0.337
202009 2.820 130.118 3.431
202012 0.135 130.889 0.163
202103 -3.647 131.771 -4.382
202106 1.150 134.084 1.358
202109 3.380 135.847 3.939
202112 5.370 138.161 6.154
202203 -0.206 138.822 -0.235
202206 1.970 142.347 2.191
202209 1.830 144.661 2.003
202212 2.960 145.763 3.215
202303 1.036 146.865 1.117
202306 2.900 150.280 3.055
202309 1.630 151.492 1.703
202312 1.900 152.924 1.967
202403 1.936 153.035 2.003
202406 3.470 155.789 3.526
202409 2.970 157.882 2.978
202412 1.060 158.323 1.060

Add all the adjusted EPS together and divide 10 will get our e10.


Parnax Lab  (BOM:506128) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Parnax Lab's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=108.15/5.26
=20.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Parnax Lab was 39.74. The lowest was 8.57. And the median was 18.23.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Parnax Lab E10 Related Terms

Thank you for viewing the detailed overview of Parnax Lab's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnax Lab Business Description

Traded in Other Exchanges
N/A
Address
104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.

Parnax Lab Headlines

No Headlines